Status:
RECRUITING
A Real World Study of Respiratory Critical Disease.
Lead Sponsor:
Ming Zhong
Conditions:
ARDS (Acute Respiratory Distress Syndrome)
Real World Study
Eligibility:
All Genders
18+ years
Brief Summary
Acute Respiratory Distress Syndrome (ARDS) is a form of acute diffuse lung injury caused by various etiologies, which rapidly progresses to acute respiratory failure. It is characterized by a sudden o...
Eligibility Criteria
Inclusion
- Patients with underlying diseases associated with high risk of ARDS, including but not limited to: sepsis, pneumonia, multiple trauma, pulmonary contusion, inhalation injury, massive blood transfusion, other high-risk conditions, or other factors causing excessive respiratory drive.
- Patients meeting the inclusion criteria for a high-risk ARDS population.
- Patients (or legal representatives) who have provided a signed and dated informed consent form.
Exclusion
- Age under 18 years.
- HIV infection.
- Known immunodeficiency disorders (e.g., leukemia, common variable immunodeficiency, etc.).
- History of solid organ or bone marrow transplantation.
- Receiving treatment with G-CSF or GM-CSF.
- Patients with a decision to withdraw from active treatment.
Key Trial Info
Start Date :
March 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT07165717
Start Date
March 1 2019
End Date
December 31 2025
Last Update
September 10 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fudan University, Zhong Shan Hospital
Shanghai, Shanghai Municipality, China, 200032